Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasm Follicular 1

Interventions

Cisplatin 5lenvatinib 4Fentanyl 4Morphine 3Fluorouracil 3Docetaxel 3trametinib 2selpercatinib 2pralsetinib 2pembrolizumab 2nimotuzumab 2larotrectinib 2dabrafenib 2cabozantinib 2anlotinib 2Thyrotropin Alfa 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Norepinephrine 2Metformin 2Indocyanine Green 2Gabapentin 2Cinacalcet 2Cetuximab 2Carboplatin 2Benzydamine 2Acetaminophen 2xiaojin wan 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × strontium chloride × Head & Neck × Clear all
NCT05466812 2022-07-20

Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases

Peking Union Medical College Hospital

Phase 4 Unknown
20 enrolled
Head & Neck

Thyroid Neoplasm Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡